From Discovery To Development To Delivery
AZBio is committed to building a top-tier life science industry in Arizona.
Arizona has a sizable and rapidly growing bioscience industry. State bioscience firms employed 25,686 in 2016 in 1,310 individual business establishments. Industry employment has grown by 9 percent since 2014, twice the growth rate of the nation, with four of the five major subsectors adding jobs during the period. Both drugs and pharmaceuticals and research, testing and medical labs have experienced double-digit job growth since 2014. Arizona inventors have been awarded nearly 2,000 bioscience-related patents since 2014, among the second quintile of states in patent activity. Since 2015, NIH awards to Arizona institutions have increased, reaching $189 million in FY 2017. (Get The Facts)
AZBio Members Are Making LIFE Bettter
AZBio Members discover, develop, and deliver life-saving and life-changing innovations.
Get Connected With Arizona's Bioindustry
A key component in Arizona’s life science ecosystem, the Arizona Bioindustry Association (AZBio) is the only statewide organization exclusively focused on Arizona’s bioscience industry. AZBio membership includes patient advocacy organizations, life science innovators, educators, healthcare partners and leading business organizations. AZBio is the statewide affiliate of the Biotechnology Innovation Organization (BIO) and works in partnership with AdvaMed, MDMA, and PhRMA to advance innovation and to ensure that the value delivered from life-changing and life-saving innovation benefits people in Arizona and around the world.
Success Stories – Good News from Arizona’s BioIndustry
OLD BOUTIQUE GETS NEW LIFE AS DPR CONSTRUCTION’S HEADQUARTERS: Adaptive reuse project showcases sustainable building design Rising from the remains of the former Castle Boutique on 44h Street and Van Buren,DPR Construction’s new Phoenix headquarters – the DPR Boutique – opened on October 14, 2011 as a living laboratory for how to live and work […]
October 20, 2011 , WASHINGTON, D.C. Ann-Marie Lynch, executive vice president of the Advanced Medical Technology Association (AdvaMed), released the following statement regarding the Centers for Medicare and Medicaid Services (CMS) final rule on Accountable Care Organizations (ACOs):
Phoenix’s VisionGate Inc has raised $2 million in the first portion of equity financing raised from existing and new investors. The company has developed a non-invasive test for the early detection of lung cancer using 3D cell imaging from a single sputum sample.
As seen on the 360 Vantage Blog Our sincerest thanks to Joan Koerber-Walker, CEO of AZBio, and her entire team for their outstanding leadership in putting together last week’s AZBio EXPO and Awards Dinner. This annual event was truly the state’s premier gathering of innovators and leaders in the bioscience community, and we were extremely […]
- The Rocky Mountain Life Science Investor & Partnering Conference
- 09/04/2019 - 09/05/2019
- RESI 2019 - Boston
- The MedTech Conference 2019
- 09/23/2019 - 09/25/2019
- Arizona Bioscience Week - AZBW 2019
- 09/30/2019 - 10/04/2019
- Discovering New Medicines in Arizona Summit